Larvol Delta - PROGRESSAD-Efficacy-and-Safety-of-GSK4527226-AL101-in-Participants-With-Early-Alzheimer39s-Disease

GSK4527226 - GSK

http://clinicaltrials.gov/ct2/show/NCT06079190

Apr 8, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next